MENU
SLN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Silence Therapeutics (SLN) Ownership - Who owns Silence Therapeutics?
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more
Profile
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
134.59M
P/E Ratio
N/A
Total Cash
147.33M
Projected Growth
N/A
Total Debt
117K
Revenue
43.26M
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash/Share
3.12
Total Debt/Equity
N/A
Revenue/Share
0.94 USD as % of share price
Fundamentals
SLN
Capitalization
135M
P/E Ratio
N/A
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash
147M
Total Cash/Share
3.12
Total Debt
117K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.94%
Revenue
43.3M
ROE
N/A
Book Value
134M
P/B Ratio
1.07
Cash Flow
N/A
Earnings
-0.99
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10.3M
Current Ratio
11.14
Current Revenue Per Employee
209722.08
Dividends Per Share - Security
N/A
EBITDA
-48.99M
Float
N/A
Float - Current
N/A
Gross Income Margin
93.40
Revenue To Assets
-28.13
Shares Held By Institutions
161M
Shares Outstanding - Current
47.2M
Total Liabilities
68.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-51.308
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com